Grant: Master's Award: Canada Graduate Scholarships
University of Calgary
$17,500.00
The gut-brain axis in a mouse model of amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD)
FY 2019-20
Summary
" Amyotrophic lateral sclerosis (ALS) is a fatal disorder where the cells in the brain and spinal cord that control muscle movement gradually break down and die. As a result, ALS gradually leads to paralysis. ALS symptoms are also seen in patients with frontotemporal dementia (FTD), a disorder with a loss of brain cells in the frontal and temporal lobes. ALS-FTD patients not only develop paralysis, but they also display memory issues and language problems. Currently, there is no way to prevent or cure either ALS or FTD. Recent research suggests that the gut-brain axis (the communication between the gut and the brain) may be critical for the disease progression of ALS-FTD. Millions of microorganisms such as bacteria, viruses, and fungi inhabit our gut and are referred to as the ""gut microbiome"". In ALS patients, the composition of the gut microbiome is significantly different compared to non-ALS individuals. Interestingly, the levels of lipopolysaccharides (LPS), a toxin released from certain types of bacteria, are abnormally increased in ALS patients. Furthermore, LPS is known to alter the gut structure and affect the immune system. However, the link between LPS, the gut, and the brain is poorly understood My research aims to examine the roles of LPS from different bacteria species on the gut-brain axis of a mouse model of ALS-FTD. Specifically, I will examine the effects of different LPS on the immune response, the gut structure, and the brain cells. I hypothesize that different LPS types will have different effects on the gut microbiome and gut-brain axis, thereby impacting how ALS-FTD progresses. I expect that my research will contribute to identifying new molecules for the diagnosis and treatment of ALS-FTD."
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
428939
Name
Lee Sukyoung
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The gut-brain axis in a mouse model of amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD)
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Amyotrophic Lateral Sclerosis; Frontotemporal Dementia; Gram Negative Bacteria; Gut-Brain Axis; Intestinal Dysbiosis; Leaky Gut; Lipopolysaccharides; Microbiome; Neurodegeneration; Tdp-43
Abstract
" Amyotrophic lateral sclerosis (ALS) is a fatal disorder where the cells in the brain and spinal cord that control muscle movement gradually break down and die. As a result, ALS gradually leads to paralysis. ALS symptoms are also seen in patients with frontotemporal dementia (FTD), a disorder with a loss of brain cells in the frontal and temporal lobes. ALS-FTD patients not only develop paralysis, but they also display memory issues and language problems. Currently, there is no way to prevent or cure either ALS or FTD. Recent research suggests that the gut-brain axis (the communication between the gut and the brain) may be critical for the disease progression of ALS-FTD. Millions of microorganisms such as bacteria, viruses, and fungi inhabit our gut and are referred to as the ""gut microbiome"". In ALS patients, the composition of the gut microbiome is significantly different compared to non-ALS individuals. Interestingly, the levels of lipopolysaccharides (LPS), a toxin released from certain types of bacteria, are abnormally increased in ALS patients. Furthermore, LPS is known to alter the gut structure and affect the immune system. However, the link between LPS, the gut, and the brain is poorly understood My research aims to examine the roles of LPS from different bacteria species on the gut-brain axis of a mouse model of ALS-FTD. Specifically, I will examine the effects of different LPS on the immune response, the gut structure, and the brain cells. I hypothesize that different LPS types will have different effects on the gut microbiome and gut-brain axis, thereby impacting how ALS-FTD progresses. I expect that my research will contribute to identifying new molecules for the diagnosis and treatment of ALS-FTD."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lee, Sukyoung
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~